In this month’s Clinical Considerations, we learn from a new study that laser treatment following isotretinoin therapy can possibly be initiated sooner than we thought; researchers have shown microwave technology may reduce underarm odor, and glean guidance for diagnosing mycosis fungoides.
Patients on Medicare who receive prescriptions for acne and rosacea from specialists pay more for those medications than they would from a primary care physician, according to results of a new study.
A nitric oxide-releasing gel to treat acne vulgaris has been found to be extremely safe, according to three Phase 1 pharmacokinetic clinical trials.
The goal of a tiered approach to acne is to improve both the patient’s acne and quality of life, while promoting responsible use of antibiotics.
Many dermatologists use spironolactone as a treatment in conjunction with traditional therapies, birth control and other hormonal modalities to help with the hormonal component of acne in adult women.
The clinical presentation of acne vulgaris in darker-skinned individuals differs in many ways from the white population, including some specific exacerbating factors that are due to cultural skin and hair-care practices.
The tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.
This month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
The difference between acne and healthy skin is largely dependent on the balance of the skin microbiota, according to study results.
A new study finds that use of dual laser therapy alone in skin types V and VI achieves excellent results with an exceptional side-effect profile.